Nalu’s technology consistently delivers “80-50-70” results, regardless of the nerve treated.
80%+
of patients using Nalu
50%+
achieve 50% or more pain relief by study end
70%+
average pain reduction of Nalu Patients
Repeated 80-50-70 results in Nalu clinical studies
Consistent real-world outcomes confirming clinical study results
Improved economics for payers, patients, and society
Durable outcomes created by Nalu's advanced technology
Clinical Trials
Repeated 80-50-70 results in Nalu clinical studies
92%
Are very satisfied or satisfied with the system (12 months)
Nalu’s responder rates are consistently 70% better than published competitor responder rates.**
*Bioness used a 30% bar for responders which is 20% lower than the 50% bar used by Nalu
§ Goree et al. 2024
**This is not head to head trial
COMFORT (1 Year)
A landmark clinical study for PNS
Nalu PNS was highly effective versus control regardless of treated target
87% responder rate (≥50% pain relief) with 69% average pain relief
Real-World Evidence
Consistent real-world outcomes confirming clinical study results
4M+
Real-world data captures variability that may be missed inside a controlled setting and provides an additional perspective into patient and provider impact. With over 4M+ patient days since launch, we have a significant and growing data set.
94%
Providers: 94% agreed that successful permanent PNS may reduce opioid use
Real World Evidence from 2,300+ Patients
33 different nerves and 34 nerve combinations treated
94% responder rate for MCID (PGIC)
Health Economic Data
Improved economics for payers, patients, and society
50%
Reduction in total medical costs (1 yr pre vs 1 yr post implant)
All information is based on actual claims data as opposed to a model.
31% reduction in number of patients using opioids
22% reduction in pharmacy costs
Change in Healthcare resource utilization and costs 12 months before and 12 months after Nalu PNS implant
Following PNS implantation, healthcare costs and opioid use were reduced compared to conventional treatment alone
61% reduction in outpatient costs
16% reduction in outpatient doctor visits
Technology
Durable outcomes created by Nalu's advanced technology
The Nalu micro-IPG has more complex programming capabilities than other PNS system
Nalu continues to explore new and better ways to understand optimal treatment to improve patient care.
Our latest paper explores the optimal stimulation of nerves as we look to enhance patient outcomes.
No other neurostimulation solution has the proven clinical safety and effectiveness of Nalu.
Explore over 100 manuscripts, posters, and abstracts below that show the safety, consistency, and effectiveness of Nalu. Use the filters to narrow your search.